For India’s tribal students, northern and northeastern states see amongst the highest declines in enrollment from elementary to secondary school levels, while southern states perform better. @Vijay__Jadhav analyses school enrollment in 4 charts:

In 2023-24, 97% tribal girls aged 6-10 were enrolled in primary school, but the number drops to 79% at the secondary stage (grades IX-X), and further to 48% for grades XI-XII. Our #DataViz in four charts:

Nearly all tribal children aged 6–10 go to school. But by age 16–17, fewer than half remain enrolled. The sharpest drop is seen after grade VIII. @Vijay__Jadhav analyses school enrolment in four charts:

Despite strong enrolment in early grades, many #ScheduledTribe students don’t make it past grade VIII. In comparison, across all social groups, enrolment rates are lower in primary #school, but a higher number make it to high school. Our #DataViz in 4 charts:

For India’s #tribal students, northern and northeastern states see amongst the highest declines in enrollment from elementary to secondary #school levels, while southern states perform better. @Vijay__Jadhav analyses school enrollment in 4 charts:

In 2023-24, 97% tribal girls aged 6-10 were enrolled in primary #school, but the number drops to 79% at the secondary stage (grades IX-X), and further to 48% for grades XI-XII. Our #DataViz in four charts:

Nearly all tribal #children aged 6–10 go to school. But by age 16–17, fewer than half remain enrolled. The sharpest drop is seen after grade VIII. @Vijay__Jadhav analyses #school enrolment in four charts:

In Rajasthan, for every TB patient receiving treatment in the private sector, 7x are not, many for fear of being stigmatised. Such missed cases end up spreading the disease in the community. How can these patients be encouraged to seek treatment?

Lack of testing accounts for the highest number of patients lost in the #TB care cascade. While access to testing and active case-finding are being improved, stigma keeps many patients from getting tested. How can India address this? Read on:

Pvt pharmacies are mandated to report #TB patients issued anti-TB drugs and maintain info of the prescriber. But barely 5% registered pharmacies reported this in 2022. Why did so few conform? And what can be done about it? @charubahri reports

Cough syrup sales can predict #TB incidence, but private pharmacies need to be roped in to look for signs, encourage testing. @charubahri explains how they can be empowered

#TB patients, family members & frontline workers interacting with them face stigmas. Female patients are 13x more likely to be stigmatised, less knowledgeable patients suffer 3x as much because they cannot face people expressing stigma, studies show. Read:

The fear of being stigmatised keeps patients with a chronic cough from getting tested for #TB. Instead, they consume cough syrup to try to suppress symptoms, in the process, spreading the disease. How can these patients be encouraged to seek treatment?

Counsellors are a vital part of #TB care but counsellor posts are vacant, a pulmonary specialist from central India reports. Inadequate funds for these operational costs could setback India’s fight against TB.

#TB patients, family members and frontline workers interacting with them face stigmas. Female patients are 13x more likely to be stigmatised, less knowledgeable patients suffer 3x as much because they cannot face people expressing stigma, studies show. Read:.

In Rajasthan, for every #TB patient receiving treatment in the private sector, 7x are not, many for fear of being stigmatised. Such missed cases end up spreading the disease in the community. How can these patients be encouraged to seek treatment?

Lack of testing accounts for the highest number of patients lost in the #TB care cascade. While access to testing and active case-finding are being improved, stigma keeps many patients from getting tested. How can India address this? Read on:

Pvt pharmacies are mandated to report #TB patients issued anti-TB drugs and maintain info of the prescriber. But barely 5% registered pharmacies reported this in 2022. Why did so few conform? And what can be done about it? @charubahri reports:

Cough syrup sales can predict #TB incidence, but private pharmacies need to be roped in to look for signs, encourage testing. @charubahri explains how they can be empowered

The fear of being stigmatised keeps patients with a chronic cough from getting tested for #TB. Instead, they consume cough syrup to try to suppress symptoms, in the process, spreading the disease. How can these patients be encouraged to seek treatment? #Tuberculosis